In this article we walk through what Oura actually said, why the numbers behind the pause are so encouraging, how the company's position compares with another very high-profile listing that has also been put on ice, and why delays of this kind so often turn out to be short-term. If you were hoping to read a eulogy for the digital health IPO window, you may be disappointed. If you were hoping for a reason to stay optimistic about one of the most interesting consumer health com